Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-11-02 Purchase | 2026-11-04 6:47 pm | Aspen Neuroscience Inc. | ASPE | Thompson Peter A. Director 10% Owner | 1,000,000 | $15 | $15,000,000 | 3,589,132 (Indirect) | View |
| 2026-11-02 Purchase | 2026-11-04 6:43 pm | Aspen Neuroscience Inc. | ASPE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 1,000,000 | $15 | $15,000,000 | 3,589,132 (Indirect) | View |
| 2026-11-02 Purchase | 2026-11-02 9:50 pm | Aspen Neuroscience Inc. | ASPE | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH Burow Kristina GILLIS STEVEN NELSEN ROBERT 10% Owner | 1,333,333 | $15 | $19,999,995 | 2,361,074 (Indirect Direct) | View |
| 2026-11-02 Purchase | 2026-11-02 9:46 pm | Aspen Neuroscience Inc. | ASPE | ARCH Venture Partners XIV L.P. ARCH Venture Partners XIV LLC ARCH Venture Fund XIV L.P. BERNS PAUL L 10% Owner | 1,200,000 | $15 | $18,000,000 | 1,200,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-02 Conversion | 2026-11-04 6:47 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | Thompson Peter A. Director 10% Owner | 2,589,132 | $0 | 3,589,132 (Indirect) | View |
| 2026-11-02 Conversion | 2026-11-04 6:43 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2,589,132 | $0 | 3,589,132 (Indirect) | View |
| 2026-11-02 Conversion | 2026-11-02 9:50 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH Burow Kristina GILLIS STEVEN NELSEN ROBERT 10% Owner | 2,421,589 | $0 | 2,361,074 (Direct) | View |
| 2026-11-02 Conversion | 2026-11-02 9:05 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | Spaventa Andrew Director | 250,415 | $0 | 237,882 (Indirect) | View |
| 2026-11-02 Conversion | 2026-11-02 9:03 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | Hasnain Faheem Executive Chair | 36,349 | $0 | 33,778 (Indirect) | View |
Ownership | 2026-10-29 8:29 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 0 | $0 | 2,589,132 (Indirect) | View |
Ownership | 2026-10-29 8:24 pm | N/A 2036-05-12 | Aspen Neuroscience Inc. | ASPE | Boerneke Jeffrey Lee General Counsel and Secretary | 0 | $0 | 101,193 (Direct) | View |
Ownership | 2026-10-29 8:16 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | Spaventa Andrew Director | 0 | $0 | 356,647 (Direct) | View |
Ownership | 2026-10-29 8:14 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | Hasnain Faheem Executive Chair | 0 | $0 | 131,818 (Direct) | View |
Ownership | 2026-10-29 8:11 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH Burow Kristina GILLIS STEVEN NELSEN ROBERT 10% Owner | 0 | $0 | 2,421,589 (Direct) | View |
Ownership | 2026-10-29 8:10 pm | N/A 2030-09-24 | Aspen Neuroscience Inc. | ASPE | Daniel Thomas O Director | 0 | $0 | 113,819 (Direct) | View |
Ownership | 2026-10-29 8:05 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | Thompson Peter A. Director 10% Owner | 0 | $0 | 2,589,132 (Indirect) | View |
Ownership | 2026-10-29 8:04 pm | N/A N/A | Aspen Neuroscience Inc. | ASPE | McDevitt Damien See Remarks | 0 | $0 | 1,145,531 (Indirect) | View |
Ownership | 2026-10-29 7:57 pm | N/A 2031-06-30 | Aspen Neuroscience Inc. | ASPE | Peterson Caryn Director | 0 | $0 | 56,356 (Direct) | View |
Ownership | 2026-10-29 7:55 pm | N/A 2035-03-12 | Aspen Neuroscience Inc. | ASPE | Meeter Dalen Chief Financial Officer | 0 | $0 | 224,141 (Direct) | View |
Ownership | 2026-10-29 7:48 pm | N/A 2032-09-06 | Aspen Neuroscience Inc. | ASPE | Raineri Kim Chief Technology Officer | 0 | $0 | 182,146 (Direct) | View |
Ownership | 2026-10-29 7:47 pm | N/A 2034-03-27 | Aspen Neuroscience Inc. | ASPE | Johnson-Pratt Lisa Chief Commercial Officer | 0 | $0 | 146,729 (Direct) | View |